INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 428m ago
HOUSE PTR27m ago
SEC 13F27m ago
ROBINHOOD CHAIN27m ago
SEC FORM 4/Open-market purchaseVerified data

Kaster Deborah bought ADGM

Chief Financial Officer · Adagio Medical Holdings, Inc. · Common Stock

Side
BUY
Value
$18K
Shares
15.0K
Price
$1.2
Executed
Dec 16, 2025
Disclosed
Dec 18, 2025
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Dec 16 executedDec 18, 2025 disclosed

ADGM · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
46/ 100 · ELEVATED
Methodology →
  • Transaction type+20 / 20

    Open-market purchase

  • Relative size+13 / 25

    $18K reported value · new position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering+5 / 15

    1 other actor traded the same direction within 14 days

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · ADGM

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    27
    MK
    Mirsaeedi-Farahani KeyvanDirector
    ADGMAdagio Medical Holdings, Inc.
    Other acquisition or disposition
    		J—
    12.8K sh
    		Sep 27, 2024Oct 13, 2026
    traded Sep 27, 2024
    		+746dSEC FORM 4

    Evidence

    24
    MO
    Mishan OrlyDirector
    ADGMAdagio Medical Holdings, Inc.
    Grant or award
    		A—
    100.0K sh
    		Jun 16, 2026Aug 12, 2026
    traded Jun 16, 2026
    		+57dSEC FORM 4

    Evidence

    24
    SS
    Salmon SeanDirector
    ADGMAdagio Medical Holdings, Inc.
    Grant or award
    		A—
    30.0K sh
    		Jun 16, 2026Aug 12, 2026
    traded Jun 16, 2026
    		+57dSEC FORM 4

    Evidence

    24
    MP
    Moran Timothy P.Director
    ADGMAdagio Medical Holdings, Inc.
    Grant or award
    		A—
    30.0K sh
    		Jun 16, 2026Aug 12, 2026
    traded Jun 16, 2026
    		+57dSEC FORM 4

    Evidence

    24
    MK
    Mirsaeedi-Farahani KeyvanDirector
    ADGMAdagio Medical Holdings, Inc.
    Grant or award
    		A—
    30.0K sh
    		Jun 16, 2026Aug 12, 2026
    traded Jun 16, 2026
    		+57dSEC FORM 4

    Evidence

    5
    UT
    Usen ToddDirector, Chief Executive Officer
    ADGMAdagio Medical Holdings, Inc.
    Grant or award
    		A—
    800.0K sh
    		Mar 6, 2026Mar 9, 2026
    traded Mar 6, 2026
    		+3dSEC FORM 4

    Evidence

    5
    KD
    Kaster DeborahChief Financial Officer
    ADGMAdagio Medical Holdings, Inc.
    Grant or award
    		A—
    490.5K sh
    		Mar 6, 2026Mar 9, 2026
    traded Mar 6, 2026
    		+3dSEC FORM 4

    Evidence

    49
    UT
    Usen ToddDirector, Chief Executive Officer
    ADGMAdagio Medical Holdings, Inc.
    Open-market purchase
    		BUY$226K
    207.3K sh
    		Dec 12, 2025Dec 15, 2025
    traded Dec 12, 2025
    		+3dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002089223-25-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Dec 16, 2025
    Published
    Dec 18, 2025
    Ingested by INSIDER
    Nov 5, 04:26 UTC
    Last re-read
    Nov 5, 04:26 UTC

    Extracted facts

    Filer
    Kaster Deborah
    Role
    Chief Financial Officer
    Transaction
    Open-market purchaseAs filed: “P”
    Asset
    Adagio Medical Holdings, Inc.
    Ticker
    ADGM
    Shares
    15.0K
    Price per share
    $1.2
    Value
    $17,973
    Execution date (reported)
    Dec 16, 2025
    Owned after transaction
    15.0K shares
    Days from execution to publication
    2

    Calculation

    Value = shares × reported price per share

    • Shares: 15.0K
    • Price: $1.1982

    = $17,973

    What this establishes

    Kaster Deborah filed this Form 4 reporting a open-market purchase of ADGM on Dec 16, 2025. It became public on Dec 18, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Chief Financial Officer
    Kaster Deborahcik:0002089223
    Issuer
    Adagio Medical Holdings, Inc.cik:0002006986

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.